Lufeng Liang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 3
- Kruppel-like factors research 2
- Oncology 8
- Peptidase Inhibition and Analysis 6
- Co-authors
- Qiong Zou (19 shared papers)Senlin Chen (19 shared papers)Zhulin Yang (15 shared papers)Jinghe Li (17 shared papers)Xiongying Miao (8 shared papers)Meigui Chen (7 shared papers)Yuan Yuan (5 shared papers)Guixiang Zeng (6 shared papers)
- Journals
- Cancer Investigation (2 papers)Pathology & Oncology Research (2 papers)Journal of Molecular Histology (2 papers)Disease Markers (1 paper)International Journal of Clinical and Experimental Pathology (1 paper)
- Partner nations
- China
In The Last Decade
Lufeng Liang
20 papers receiving 474 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 104
- Cell Biology 63
- Oncology 89
- Molecular Biology 227
- Immunology and Allergy 18
Countries citing papers authored by Lufeng Liang
This map shows the geographic impact of Lufeng Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lufeng Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lufeng Liang more than expected).
Fields of papers citing papers by Lufeng Liang
This network shows the impact of papers produced by Lufeng Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lufeng Liang. The network helps show where Lufeng Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lufeng Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. | 2013 | 70 |
| 2 | 2013 | 46 | |
| 3 | 2013 | 43 | |
| 4 | 2016 | 33 | |
| 5 | 2013 | 31 | |
| 6 | LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis. | 2015 | 30 |
| 7 | 2014 | 25 | |
| 8 | 2014 | 25 | |
| 9 | 2013 | 23 | |
| 10 | 2012 | 22 | |
| 11 | 2016 | 21 | |
| 12 | 2015 | 21 | |
| 13 | 2014 | 20 | |
| 14 | 2013 | 16 | |
| 15 | 2013 | 13 | |
| 16 | 2016 | 13 | |
| 17 | 2014 | 9 | |
| 18 | 2016 | 7 | |
| 19 | 2013 | 4 | |
| 20 | 2014 | 4 |
About Lufeng Liang
Lufeng Liang is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Immunology, having authored 20 papers that have together received 476 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (3 papers), Cancer Mechanisms and Therapy (2 papers), NF-κB Signaling Pathways (2 papers), Galectins and Cancer Biology (2 papers) and Kruppel-like factors research (2 papers). The work is most often cited by research in Cancer Research (104 citations), Cell Biology (63 citations), Oncology (89 citations), Molecular Biology (227 citations) and Immunology and Allergy (18 citations). Lufeng Liang has collaborated with scholars based in China. Frequent co-authors include Qiong Zou, Senlin Chen, Zhulin Yang, Jinghe Li, Xiongying Miao, Meigui Chen, Yuan Yuan, Guixiang Zeng, Yuan Yuan and Daiqiang Li. Their work appears in journals such as Cancer Investigation, Pathology & Oncology Research, Journal of Molecular Histology, Disease Markers and International Journal of Clinical and Experimental Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.